Cancer effect effects anticancer drugs or radiation. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy9

Cell Line, Tumor Tumor Cells, Cultured HCT116 Cells MCF-7 Cells HT29 Cells Cell Line Neoplastic Stem Cells HeLa Cells Breast

Organisms4

Mice, Nude Mice, Inbred BALB C Mice, SCID Mice, Inbred C57BL

Diseases42

Radiation Injuries Neoplasms Breast Neoplasms Colonic Neoplasms Lung Neoplasms Ovarian Neoplasms Neoplasms, Radiation-Induced Prostatic Neoplasms Radiation Injuries, Experimental Stomach Neoplasms Neoplasm Metastasis Radiation Pneumonitis Pancreatic Neoplasms Neoplasm Invasiveness Carcinoma, Squamous Cell Carcinoma, Non-Small-Cell Lung Carcinoma Uterine Cervical Neoplasms Adenocarcinoma Head and Neck Neoplasms Neoplasms, Experimental Colorectal Neoplasms Neoplasm Recurrence, Local Disease Progression Urinary Bladder Neoplasms Brain Neoplasms Cell Transformation, Neoplastic Genetic Predisposition to Disease Liver Neoplasms Neovascularization, Pathologic Rectal Neoplasms Acute Radiation Syndrome Melanoma Skin Neoplasms Esophageal Neoplasms Bone Neoplasms Endometrial Neoplasms Mammary Neoplasms, Experimental Carcinoma, Small Cell Neoplasms, Second Primary Radiodermatitis Disease Models, Animal

Chemicals and Drugs76

Antineoplastic Agents Antineoplastic Agents, Phytogenic Cisplatin Doxorubicin Antibiotics, Antineoplastic Paclitaxel Neoplasm Proteins Drug Carriers Radiation-Sensitizing Agents Camptothecin Fluorouracil Tumor Suppressor Protein p53 Etoposide Ellipticines P-Glycoprotein RNA, Messenger RNA, Small Interfering Antimetabolites, Antineoplastic Cancer Vaccines Enzyme Inhibitors DNA, Neoplasm Anticarcinogenic Agents Tumor Markers, Biological Prodrugs Organoplatinum Compounds Plant Extracts Radiation-Protective Agents Proto-Oncogene Proteins c-bcl-2 DNA-Binding Proteins Caspases DNA Caspase 3 Platinum Deoxycytidine Topoisomerase I Inhibitors Receptor, erbB-2 DNA Topoisomerases, Type II Daunorubicin Taxoids Mitomycin Antibodies, Monoclonal Antigens, Neoplasm Tumor Suppressor Proteins Antineoplastic Agents, Alkylating Nanocapsules Receptors, Estrogen Protein Kinase Inhibitors Vinblastine Receptor, Epidermal Growth Factor Mitoxantrone DNA Adducts Protein-Serine-Threonine Kinases Prostate-Specific Antigen Tamoxifen Cobalt Radioisotopes Proto-Oncogene Proteins c-akt Nuclear Proteins Multidrug Resistance-Associated Proteins Reactive Oxygen Species ATP-Binding Cassette Transporters Cell Cycle Proteins Bleomycin Drugs, Investigational Histone Deacetylase Inhibitors Proto-Oncogene Proteins Quinazolines Indoles Tubulin Modulators Poly(ADP-ribose) Polymerases Intercalating Agents Antineoplastic Agents, Hormonal Topoisomerase II Inhibitors Anthracyclines Carboplatin RNA, Neoplasm Apoptosis Regulatory Proteins

Analytical, Diagnostic and Therapeutic Techniques and Equipment66

Radiation Dosage Dose-Response Relationship, Radiation Drug Screening Assays, Antitumor Radiation Monitoring Early Detection of Cancer Xenograft Model Antitumor Assays Drug Delivery Systems Combined Modality Therapy Radiotherapy Radiation Injuries, Experimental Drug Carriers Antineoplastic Combined Chemotherapy Protocols Radiotherapy Dosage Neoplasm Transplantation Inhibitory Concentration 50 Blotting, Western Radiometry Survival Analysis Transplantation, Heterologous Reverse Transcriptase Polymerase Chain Reaction Molecular Targeted Therapy Drug Design Survival Rate Prognosis Tumor Burden Retrospective Studies Gene Expression Profiling Models, Biological Clinical Trials as Topic Neoplasms, Experimental Follow-Up Studies Neoplasm Staging Flow Cytometry Transfection Drug Evaluation, Preclinical Treatment Outcome Disease-Free Survival Risk Radiotherapy, Adjuvant Prospective Studies Risk Assessment Drug Discovery Chemotherapy, Adjuvant Dose Fractionation Oligonucleotide Array Sequence Analysis Nanocapsules Registries Sensitivity and Specificity Tumor Stem Cell Assay Reproducibility of Results Drug Administration Schedule Radiotherapy Planning, Computer-Assisted Risk Factors Clinical Trials, Phase I as Topic Gene Knockdown Techniques Tomography, X-Ray Computed Mammary Neoplasms, Experimental Radiation Hybrid Mapping Radiotherapy, Conformal Kaplan-Meier Estimate Odds Ratio Polymerase Chain Reaction Phytotherapy SEER Program Disease Models, Animal Multivariate Analysis

Phenomena and Processes55

Radiation Dosage Radiation, Ionizing Dose-Response Relationship, Radiation Radiation Tolerance Radiation Drug Resistance, Neoplasm Apoptosis Cell Survival Gene Expression Regulation, Neoplastic Cell Proliferation DNA Damage Gamma Rays Cosmic Radiation Dose-Response Relationship, Drug Cell Cycle Inhibitory Concentration 50 Drug Synergism Ultraviolet Rays Drug Resistance, Multiple Background Radiation Mutation Cell Division DNA Repair Time Factors Signal Transduction Down-Regulation Radiation Effects Molecular Structure Transfection Risk Genetic Predisposition to Disease Cell Death Cell Growth Processes Base Sequence Phosphorylation Up-Regulation RNA Interference X-Rays Sensitivity and Specificity DNA Adducts Genes, p53 Cell Movement Gene Expression Promoter Regions, Genetic DNA Methylation Enzyme Activation Structure-Activity Relationship Gene Silencing Drug Resistance Odds Ratio Polymorphism, Genetic Phenotype G2 Phase Genes, MDR Protein Binding

Disciplines and Occupations6

Radiation Oncology Drug Design Nanomedicine Medical Oncology Drug Discovery Radiobiology

Anthropology, Education, Sociology and Social Phenomena2

National Cancer Institute (U.S.)Nuclear Warfare

Technology, Industry, Agriculture3

Nanoparticles Nanomedicine Nanocapsules

Information Science7

Survival Rate Molecular Sequence Data Base Sequence Registries Radiotherapy Planning, Computer-Assisted Radiotherapy, Conformal SEER Program

Named Groups1

Health Care32

Radiation Dosage Radiation Injuries Dose-Response Relationship, Radiation Radiation Protection Radiation Monitoring Cosmic Radiation Radiation Injuries, Experimental Ultraviolet Rays Survival Analysis National Cancer Institute (U.S.)Survival Rate Retrospective Studies Clinical Trials as Topic Radiation Effects Follow-Up Studies Treatment Outcome Disease-Free Survival Risk Prospective Studies Risk Assessment Acute Radiation Syndrome Registries Sensitivity and Specificity Radioactive Hazard Release Age Factors Reproducibility of Results Risk Factors Clinical Trials, Phase I as Topic Kaplan-Meier Estimate Odds Ratio SEER Program Multivariate Analysis

Geographicals2

United States Japan

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Information Science Named Groups Health Care Geographicals

Antineoplastic Agents Radiation Dosage Radiation, Ionizing Radiation Injuries Dose-Response Relationship, Radiation Radiation Tolerance Cell Line, Tumor Neoplasms Drug Screening Assays, Antitumor Radiation Radiation Protection Radiation Monitoring Drug Resistance, Neoplasm Apoptosis Cell Survival Mice, Nude Antineoplastic Agents, Phytogenic Breast Neoplasms Cisplatin Early Detection of Cancer Doxorubicin Xenograft Model Antitumor Assays Radiation Oncology Colonic Neoplasms Antibiotics, Antineoplastic Tumor Cells, Cultured Drug Delivery Systems Lung Neoplasms Gene Expression Regulation, Neoplastic Ovarian Neoplasms Neoplasms, Radiation-Induced Combined Modality Therapy Prostatic Neoplasms Radiotherapy Cell Proliferation DNA Damage Gamma Rays Paclitaxel Cosmic Radiation Neoplasm Proteins Radiation Injuries, Experimental Drug Carriers Antineoplastic Combined Chemotherapy Protocols Dose-Response Relationship, Drug Radiation-Sensitizing Agents Stomach Neoplasms Cell Cycle Neoplasm Metastasis Radiation Pneumonitis Pancreatic Neoplasms Camptothecin Fluorouracil Radiotherapy Dosage Tumor Suppressor Protein p53 Neoplasm Invasiveness Neoplasm Transplantation Etoposide Carcinoma, Squamous Cell Inhibitory Concentration 50 Drug Synergism Ultraviolet Rays Ellipticines Blotting, Western Drug Resistance, Multiple Background Radiation P-Glycoprotein Radiometry Survival Analysis RNA, Messenger National Cancer Institute (U.S.)Carcinoma, Non-Small-Cell Lung Mutation Transplantation, Heterologous Cell Division RNA, Small Interfering Carcinoma Reverse Transcriptase Polymerase Chain Reaction Molecular Targeted Therapy Uterine Cervical Neoplasms Antimetabolites, Antineoplastic Cancer Vaccines DNA Repair Enzyme Inhibitors Drug Design Survival Rate Adenocarcinoma Prognosis DNA, Neoplasm Tumor Burden Retrospective Studies Gene Expression Profiling Time Factors Signal Transduction Head and Neck Neoplasms Models, Biological Anticarcinogenic Agents Down-Regulation Clinical Trials as Topic Radiation Effects Tumor Markers, Biological

No FAQ available that match "cancer effect effects anticancer drugs or radiation"